.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Cipla
Mallinckrodt
Medtronic
Citi
Teva
McKinsey
Deloitte

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 125117

« Back to Dashboard

Summary for BLA: 125117

Tradename:
NAGLAZYME
Applicant:
Biomarin
Ingredient:
galsulfase
Patents:4
Approval Date:May 31, 2005
Suppliers: see list1

Pharmacology for BLA: 125117

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,277,830 ForSight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (Menlo Park, CA), Alster; Yair (Menlo Park, CA), Farinas; Kathleen Cogan (Menlo Park, CA), Gifford, III; Hanson S. (Menlo Park, CA), MacFarlane; K. Angela (Menlo Park, CA), Reich; Cary J. (Menlo Park, CA), Barrett; Michael (Menlo Park, CA), Campbell; Randolph E. (Menlo Park, CA), Sutton; Douglas (Menlo Park, CA) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,399,006 Forsight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (San Francisco, CA), Alster; Yair (Palo Alto, CA), Chamow; Steven M. (San Mateo, CA), Farinas; Kathleen Cogan (Los Altos, CA), Gifford, III; Hanson S. (Woodside, CA), Macfarlane; K. Angela (Woodside, CA), Reich; Cary J. (Los Gatos, CA), Barrett; Michael (Cupertino, CA), Campbell; Randolph E. (Redwood City, CA), George; Robert (San Jose, CA), Sutton; Douglas (Pacifica, CA) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,679,778 CMC Biologics A/S (Soeborg, Copenhagen, DK) Laustsen; Mads (Copenhagen, DK) ► SubscribeRXOrphansearch
Biomarin
NAGLAZYME
galsulfase
INJECTABLE; INJECTION1251170012005-05-318,729,241 Momenta Pharmaceuticals, Inc. (Cambridge, MA) Liu; Cuihua (Belmont, MA), Xu; Xiao-Jin (Jamaica Plain, MA), Dong; Shiming (North Reading, MA), Dellorusso; Guy (Milford, MA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
Colorcon
Accenture
Dow
AstraZeneca
Covington
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot